St. John's Wort for Wound Healing

Research suggests that St. John's wort, particularly its active compounds hyperforin and hypericin, shows promise as a topical agent for wound healing based on a combination of laboratory studies, animal experiments, small clinical investigations, and traditional use documentation, though the overall evidence base remains limited and mixed. Studies indicate that proposed mechanisms include stimulation of fibroblast collagen production, anti-inflammatory activity via NF-κB pathway inhibition, and antimicrobial properties, with preclinical work and a small uncontrolled clinical study in patients with inflammatory skin lesions reporting positive outcomes, and newer formulation research suggesting that nanoencapsulated delivery systems may enhance the wound-healing potential of the extract. However, the one randomized controlled trial identified in this body of literature found no significant benefit of topical St. John's wort oil over saline for mild-to-moderate pressure injuries, and a 2014 review noted that clinical trials remain sparse and that the composition of topical preparations varies considerably depending on plant source, preparation method, and storage, all of which complicate direct comparisons across studies. On balance, the evidence is encouraging enough at the preclinical and preliminary clinical level to justify further investigation, but the current research does not yet support definitive conclusions about effectiveness for wound healing in humans.